Regulated Information

Ipsen S.A. publishes its 2025 Consolidated Financial Statements

Monthly information relative to the total number of voting rights and shares composing the share capital

PARIS, FRANCE, 29 January 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today the co-optation of Peter Guenter to its Board as a Director, effective January 28, 2026, further to the vacancy of Mr. Henri Beaufour’s position.

PARIS, FRANCE, 21 January 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced that the Arbitral Tribunal of the International Chamber of Commerce (ICC) has issued a final decision in favor of Ipsen, dismissing the claim initiated by Galderma in the arbitration…

Monthly information relative to the total number of voting rights and shares composing the share capital